Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.62
+0.13 (2.00%)
Mar 19, 2026, 11:25 AM EDT - Market open

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3904595283,3823,19712,724
Market Cap Growth
-10.42%-13.19%-84.38%5.78%-74.87%-
Enterprise Value
399.68453.23405.652,6602,29511,258
Last Close Price
6.628.319.8267.6067.60332.40
PE Ratio
--1.47-0.93-3.68-1.35-5.98
PS Ratio
2.252.702.3313.456.6940.54
PB Ratio
0.740.900.743.081.848.45
P/TBV Ratio
0.720.910.713.001.647.51
P/FCF Ratio
--2.57-1.38-10.06-10.50-41.00
P/OCF Ratio
--2.68-1.65-11.45-12.68-50.13
EV/Sales Ratio
2.352.661.7910.584.8035.87
EV/EBITDA Ratio
--1.77-0.82-3.35-1.06-6.26
EV/EBIT Ratio
--1.44-0.72-3.08-1.04-6.16
EV/FCF Ratio
--2.54-1.06-7.91-7.54-36.28
Debt / Equity Ratio
0.820.820.610.200.240.01
Debt / EBITDA Ratio
-1.63-1.63-0.88-0.28-0.19-0.01
Debt / FCF Ratio
-2.33-2.33-1.15-0.66-1.36-0.07
Net Debt / Equity Ratio
-0.01-0.01-0.17-0.66-0.52-1.01
Net Debt / EBITDA Ratio
0.020.020.250.910.420.85
Net Debt / FCF Ratio
0.030.030.322.152.964.92
Asset Turnover
0.140.140.150.120.210.23
Inventory Turnover
----121.4842.54
Quick Ratio
4.664.665.445.878.0812.51
Current Ratio
4.924.925.626.118.3812.79
Return on Equity (ROE)
-51.08%-51.08%-60.34%-63.02%-127.52%-180.29%
Return on Assets (ROA)
-25.19%-25.18%-36.76%-41.11%-95.15%-133.06%
Return on Invested Capital (ROIC)
-46.38%-46.36%-83.58%-101.67%-289.00%-545.84%
Return on Capital Employed (ROCE)
-27.49%-27.49%-40.39%-44.70%-102.68%-144.08%
Earnings Yield
-81.79%-67.87%-107.33%-27.17%-73.96%-16.73%
FCF Yield
-46.74%-38.96%-72.31%-9.94%-9.52%-2.44%
Buyback Yield / Dilution
-4.24%-4.24%-0.02%-0.00%-3.08%-11.60%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q